Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | VTGNVistagen Therapeutics, Inc.FY2026 · Mar |
|---|---|
| Revenue | $1.27M |
| Revenue, yoy | +161.1% |
| Net income | $69.69M |
| Net income, yoy | −35.5% |
| Net margin | -5,491.3% |
| Free cash flow | $25.81M |
| FCF margin | — |
| EPS, diluted | $1.83 |
Add another company.